DNA Electronics

Our mission is to bring dramatic, life-changing improvements to healthcare and beyond with fast, simple and scientifically sound products. DNAe Group Holdings LtdScale Space58 Wood Lane London W12 7RZ United Kingdom. At DNAe we are leading the way in rapid, near-patient sequencing testing that will revolutionize patient care for a range of unmet clinical needs. DNAe is developing the LiDia-SEQ™ Platform, a direct-from-specimen diagnostic system that performs DNA sequencing on a microchip, to provide rapid, actionable information to clinicians. We are creating radically different products that change the game for early diagnosis and monitoring of potentially fatal diseases. Regius Professor Chris Toumazou FRS, FREng, FMedSci founded the company in 2003, as a spin-out from Imperial College London, having invented a way of detecting protons released during DNA synthesis to enable DNA sequence detection using a standard silicon-chip based transistor. Regius Professor Chris Toumazou FRS, FREng, FMedSci founded the company in 2003, as a spin-out from Imperial College, London, having invented a way of detecting protons released during DNA synthesis to enable DNA sequence detection using a standard silicon-chip based transistor. The user-friendly system can operate in a variety of hospital environments at the point-of-need, with flexible levels of throughput to match a wide range of clinical demands.‍Our initial focus is on infectious disease diagnostics, where speed and microbial DNA sequence information can make the difference between life and death.